IL-10 production in B cells is confined to CD154+ cells in patients with systemic lupus erythematosus
- PMID: 15571932
- DOI: 10.1016/j.jaut.2004.10.001
IL-10 production in B cells is confined to CD154+ cells in patients with systemic lupus erythematosus
Abstract
The immunological hallmark of SLE is B cell hyperactivity. CD154 (CD40-L) is normally expressed in activated T cells, and plays an important role in T-B interactions. Its expression is increased in SLE T cells. Additionally, its expression on B cells leads to the development of SLE-like disease in a transgenic model. IL-10 is a key cytokine in the disturbed SLE immune system. The aim of this work was to explore the relation between IL-10 and CD154 expression in SLE B cells. We studied 11 SLE patients and 10 healthy volunteers. Mononuclear cells were isolated from peripheral blood and cultured in the presence or absence of Cowan I Strain Staphylococcus (CSS). Surface CD154 and intracytoplasmic IL-10 expression were quantified with flow cytometry. In basal conditions, CD154 expression was not different in patients and controls. B cell stimulation did not cause a significant increase in CD154 expression in control B cells. However, its expression increased 2 times in B cells obtained from SLE patients. IL-10 expression was confined to CD154(+) cells. Our results show that IL-10 production is intimately linked to CD154 expression in B cells, and that the IL-10(+)CD154(+) B cell subset increases abnormally when SLE-derived cells are stimulated with CSS.
Similar articles
-
Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.J Autoimmun. 1998 Oct;11(5):471-5. doi: 10.1006/jaut.1998.0213. J Autoimmun. 1998. PMID: 9802931
-
Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.Roum Arch Microbiol Immunol. 2006 Jan-Jun;65(1-2):66-74. Roum Arch Microbiol Immunol. 2006. PMID: 17877113 Review.
-
Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.J Clin Invest. 2003 Nov;112(10):1506-20. doi: 10.1172/JCI19301. J Clin Invest. 2003. PMID: 14617752 Free PMC article. Clinical Trial.
-
IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation.J Immunol. 2009 May 1;182(9):5623-32. doi: 10.4049/jimmunol.0802412. J Immunol. 2009. PMID: 19380809
-
The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway.Autoimmunity. 2004 Sep-Nov;37(6-7):457-64. doi: 10.1080/08916930400002386. Autoimmunity. 2004. PMID: 15621572 Review.
Cited by
-
Autoimmunity and Carcinogenesis: Their Relationship under the Umbrella of Autophagy.Biomedicines. 2023 Apr 8;11(4):1130. doi: 10.3390/biomedicines11041130. Biomedicines. 2023. PMID: 37189748 Free PMC article. Review.
-
Autoimmunity and Cancer-Two Sides of the Same Coin.Front Immunol. 2022 May 13;13:793234. doi: 10.3389/fimmu.2022.793234. eCollection 2022. Front Immunol. 2022. PMID: 35634292 Free PMC article. Review.
-
The Role of Regulatory B cells in Kidney Diseases.Front Immunol. 2021 May 24;12:683926. doi: 10.3389/fimmu.2021.683926. eCollection 2021. Front Immunol. 2021. PMID: 34108975 Free PMC article. Review.
-
Assessing the expression of immunosuppressive cytokines in the newly diagnosed systemic lupus Erythematosus patients: a focus on B cells.BMC Immunol. 2020 Nov 16;21(1):58. doi: 10.1186/s12865-020-00388-3. BMC Immunol. 2020. PMID: 33198645 Free PMC article.
-
The Immunomodulatory Effects of Mesenchymal Stem Cells on Regulatory B Cells.Front Immunol. 2020 Aug 14;11:1843. doi: 10.3389/fimmu.2020.01843. eCollection 2020. Front Immunol. 2020. PMID: 32922398 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
